Prof. Dr. Ali Akçay
Ailesel Akdeniz Ateşi (Fmf), Akut Böbrek Yetmezliği, Akut Glomerülonefritdevamı
İçerikler
Henüz Makale Yok
Bu uzmana ait henüz makale içeriği bulunmamaktadır.
Son Değerlendirme
Doktor Ali Beye diyabet ve hipertansiyona bağlı şikayetlerimle muayene oldum. Ayrıntılı bilgilendirm...devamı
Adres
Prof. Dr. Ali AkçayHaritada Gör
Casanita İş Merkezi Mustafa Kemal Mahallesi 2156. Sokak No:20/6
Çankaya/AnkaraUzmanlık Hizmetleri
Böbrek fonksiyonları
Böbrek Hastalıkları
Diyabet tedavisi
Ekg (elektrokardiyografi)
Enfeksiyonlar ve tedavisi
Fmf takip ve tedavisi
Genel sağlık taraması tetkikleri ve muayenesi
Gut takip ve tedavisi
Hdl kolesterol testi
Hipertansiyon tanı ve tedavisi
Klinik Fotoğrafları
Özgeçmiş
Mesleki Yayınlar
Görüşler
Görüşlerinizi Önemsiyoruz
Uzmanlar ile ilgili görüşlerinizi belirtmeden önce moderasyon sürecimiz hakkında daha fazlasını öğrenin.
5.0
★★★★★
Toplam 4 geribildirimZamanlama5.0
İlgi5.0
Ortam5.0
Z
ZEH*** A***04.09.2023
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0Böbrek HastalıklarıProf. Dr. Ali Akçay
A
Ayt*** A***22.05.2023
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0Böbrek HastalıklarıProf. Dr. Ali Akçay
A
Ayt*** A***22.05.2023
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0Böbrek HastalıklarıProf. Dr. Ali Akçay
Ş
Şer*** Ö***03.03.2019
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0Mesleki Bilgiler
Deneyim Süresi
Mayıs 2000 - Günümüz (25 yıl)
25 yıllık mesleki deneyim
Diploma Aldığı Kurum
Gazi Üniversitesi
Uzmanlık Aldığı Kurum
Hacettepe Üniversitesi
BASKENT ÜNIVERSITESI (ANKARA)
Deneyimler
ÖZEL KORU HASTANESİ
Yabancı Diller
English
Yayınlar
1. M. C. Savas, M. Benekli, A. Akcay, A. Birdane. Heparin-associated refractory bronchospasm. The Annals of Pharmacotherapy, 31:253, 1997. (LETTER)
2. A. Akcay, B. Altun, C. Usalan, S. Ulusoy, A. A. Kiykim, Y. Erdem, U. Yasavul, C. Turgan, S. Caglar. Hepatitis A viral infection-related acute renal failure. Nephron, 83:191–192, 1999. (LETTER)
3. A. Akcay, B. Altun, C. Usalan, S. Ulusoy, Y. Erdem, U. Yasavul, C. Turgan, S. Caglar. Cyclical acute renal failure due to bilateral ureteral endometriosis. Clinical Nephrology, 52:179-182, 1999. (CASE REPORT)
4. A. Akcay, B. Altun, C. Usalan, D. Gunes, S. Ulusoy, A. A. Kiykim, Y. Erdem, U. Yasavul, C. Turgan, S. Caglar. Rhinocerebral mucormycosis in a patient with membranous glomerulonephritis. Nephron, 86:352–3, 2000. (LETTER)
5. A. A. Kiykim, B. Altun, C. Usalan, Y. Erdem, A. Akcay, U. Yasavul, C. Turgan, S. Caglar. Extensive iliac and inferior vena cava thrombosis due to type IV crescentic glomerulonephritis. Clinical Nephrology, 54:E7-E8, 2000. (LETTER)
6. Ozdemir FN, Akcay A, Haberal M. Dialysis modalities in patients with acute renal failure. Nephrology Dialysis Transplantation, 16 (Suppl 6):18–20, 2001. (REVIEW)
7. Ozdemir FN, Akcay A, Ozdemir BH, Turan M, Demirhan B, Colak T, Arat Z, Haberal M. Significance of diagnostic procedures for renal transplant graft function. Transplantation Proceedings, 34:2096–8, 2002. (ORIGINAL ARTICLE)
8. Saatci U, Akman B, Akcay A, Ozdemir FN, Budak B, Haberal M. Effects of secondary hyperparathyroidism treatments on blood pressure and lipid levels in chronic renal failure patients. Transplantation Proceedings, 34:2041–3, 2002. (ORIGINAL ARTICLE)
9. A Akcay, Y Erdem, B Altun, C Usalan, E Agca, U Yasavul, C Turgan, S Caglar. The booster phenomenon in 2-step tuberculin skin testing of patients receiving long-term hemodialysis. American Journal of Infection Control, 31:371–374, 2003. (ORIGINAL ARTICLE)
10. S. Sezer, F. N. Ozdemir, A. Akcay, T. Colak, A. Kut, M. Haberal. Contribution of late acute rejection to long-term renal allograft survival in patients with chronic allograft nephropathy. Transplantation Proceedings, 35:2637–8, 2003. (ORIGINAL ARTICLE)
11. H. Micozkadioglu, T. Colak, A. Akcay, S. Sezer, F. B. Atac¸ H. Verdi, Z. Arat, F. N. Ozdemir, M. Haberal. Angiotensin-converting enzyme gene polymorphism significantly affects renal posttransplantation erythrocytosis. Transplantation Proceedings, 36:161–163, 2004. (ORIGINAL ARTICLE)
12. A. Akcay, F. N. Ozdemir, F. B. Atac, S. Sezer, H. Verdi, Z. Arat, M. Haberal. Angiotensin-converting enzyme genotype is a predictive factor in the peak panel-reactive antibody response. Transplantation Proceedings, 36:35–37, 2004. (ORIGINAL ARTICLE)
13. F. N. Ozdemir, S. Sezer, A. Akcay, Z. Arat, M. Turan, S. Gulmus, E. Kulah, M. Haberal. Panel reactive antibody positivity and associated HLA antibodies in Turkish renal transplant candidates. Transplant Immunology, 12:185–188, 2004. (ORIGINAL ARTICLE)
15. F. N. Ozdemir, A. Akcay, S. Sezer, Z. Arat, T. Colak, M. Turan, S. Gulmus, M. Haberal. Effect of simvastatin in the treatment of highly sensitized dialysis patients: the pre and post-renal transplantation follow-up outcomes. Transplant Immunology, 13:39–42, 2004. (ORIGINAL ARTICLE)
16. S. Sezer, F. N. Ozdemir, A. Akcay, Z. Arat, S. Boyacıoglu, M. Haberal. Renal transplantation offers a better survival in HCV infected ESRD patients. Clinical Transplantation, 18:619–623, 2004. (ORIGINAL ARTICLE)
17. A. Akcay, S. Sezer, F. N. Ozdemir, Z. Arat, F. B. Atac, H. Verdi, T. Colak, M. Haberal. Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction. Transplantation, 78:892-898, 2004. (ORIGINAL ARTICLE)
18. A. Akcay, M. Kanbay, E. Agca, S. Sezer, F. N. Ozdemir. Neutropenia due to clopidogrel in a patient with end-stage renal disease. The Annals of Pharmacotherapy, 38:1538–1539, 2004. (LETTER)
19. E. Agca, A. Akcay, H. Simsek. Ursodeoxycholic acid and terbinafine-induced toxic hepatitis. The Annals of Pharmacotherapy, 38:1088–1089, 2004. (LETTER)
20. F. N. Ozdemir, A. Akcay, S. Sezer, S. Boyacioğlu, B. H. Ozdemir, Z. Arat, M. Haberal. A six-year follow-up after interferon-alpha monotherapy for chronic hepatitis C infection in hemodialysis patients. Renal Failure, 26:583–588, 2004. (ORIGINAL ARTICLE)
21. Sezer S, Akcay A, Ozdemir FN, Kulah E, Arat Z, Haberal M. Post-transplant C-reactive protein monitoring can predict chronic allograft nephropathy. Clinical Transplantation, 18:722–725, 2004. (ORIGINAL ARTICLE)
22. S. Sezer, M. Uyar, A. Akcay, Z. Arat, E. Kulah, F. N. Ozdemir, M. Haberal. Endothelial nitric oxide synthase and angiotensin II type 1 receptor gene polymorphisms can influence chronic inflammatory state in renal transplant patients. Transplantation Proceedings, 37:776–778, 2005. (ORIGINAL ARTICLE
23. A. Akcay, F. N. Ozdemir, H. Micozkadioglu, Z. Arat, F. B. Atac, H. Verdi, F. Sahin, M. Haberal. Association of the vitamin D receptor gene polymorphisms with hypercalcemia in CAPD patients. Peritoneal Dialysis International, 25(Suppl 3): S52–55, 2005. (ORIGINAL ARTICLE)
24. Kanbay M, Yildirir A, Ulus T, Bozbas H, Bilgi M, , Muderrisoglu H, Akcay A, Ozdemir FN. Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients. Renal Failure, 27:297–303, 2005. (ORIGINAL ARTICLE)
25. Ozdemir FN, Elsurer R, Akcay A, Ozdemir BH, Sezer S, Haberal M. Seronegative systemic lupus erythematosus: etiology of nephrotic syndrome and acute renal failure in early postpartum period. Lupus, 14:629–31, 2005. (CASE REPORT
26. Ozdemir FN, Akcay A, Elsurer R, Sezer S, Arat Z, Haberal M. Interdialytic weight gain is less with Mediterranean type of diet in hemodialysis patients. Journal of Renal Nutrition, 15:371–376, 2005. (ORIGINAL ARTICLE)
27. Sezer S, Tutal E, Arat Z, Akcay A, Celik H, Ozdemir FN, Haberal M. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients. Journal of Renal Nutrition, 15:427–434, 2005. (ORIGINAL ARTICLE)
28. Kanbay M, Akcay A, Huddam B, Usluogullari CA, Arat Z, Ozdemir FN, Haberal M. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients. Transplantation Proceedings, 37:3119–3120, 2005. (ORIGINAL ARTICLE)
29. Akcay A, Kanbay M, Huddam B, Usluogullari CA, Arat Z, Ozdemir FN, Haberal M. Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients. Transplantation Proceedings, 37:3103–3105, 2005. (ORIGINAL ARTICLE)
30. Ozdemir FN, Akcay A, Bilgic A, Akgul A, Arat Z, Haberal M. Effects of smoking and blood eosinophil count on the development of arteriovenous fistulae thrombosis in hemodialysis patients. Transplantation Proceedings, 37:2918–2921, 2005. (ORIGINAL ARTICLE)
31. M. Kanbay, A. Yildirir, A. Akcay, T. Colak, F.N. Ozdemir, H. Muderrisoglu, and M. Haberal. Effects of immunosuppressive drugs on serum lipid levels in renal transplant recipients. Transplantation Proceedings, 38:502–505, 2006. (ORIGINAL ARTICLE)
32. Ozdemir FN, Afsar B, Akgul A, Usluogullari C, Akcay A, Haberal M. Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients. Transplantation Proceedings, 38:480–482, 2006. (ORIGINAL ARTICLE)
33. Aydogan T, Kanbay M, Uz B, Kaya A, Isik A, Bozalan R, Erkman M, Akcay A. Fatal hyperphosphatemia secondary to a phosphosoda bowel preparation in a geriatric patient with normal renal function. Journal of Clinical Gastroenterology, 40:177, 2006. (LETTER)
34. A Akcay, H Micozkadioglu, FB Atac, E Agca, FN Ozdemir. Relationship of ENOS and RAS gene polymorphisms to initial peritoneal transport status in peritoneal dialysis patients. Nephron, 104:c41–46, 2006. (ORIGINAL ARTICLE)
35. H Selcuk, M Korkmaz, G Gur, M Kanbay, A Akcay, FN Ozdemir, S Boyacioglu. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment. Digestive Diseases and Sciences, 51:1420–1425, 2006. (ORIGINAL ARTICLE)
36. Isik B, Bayrak R, Akcay A, Sogut S. Erdosteine against acetaminophen induced renal toxicity. Molecular and Cellular Biochemistry, 287:185–191, 2006. (ORIGINAL ARTICLE)
37. Aydogan T, Kanbay M, Uraldi C, Kaya A, Uz B, Isik A, Akcay A, Erekul S. Kikuchi Fujimoto disease secondary to Entamoeba histolytica: Case report. Journal of Infection, 53:e171–173, 2006. (CASE REPORT)
38. A Kaya, M Kanbay, O Bayrak, H Kurtaran, N Ark, F Catal, A Akcay. Concomitant nephrotic syndrome with antinuclear antibody seropositivity and hashimoto thyroiditis in a patient with mycosis fungoides. Southern Medical Journal, 99:631, 2006.
39. Kanbay M, Gur G, Akcay A, Selcuk H, Yilmaz U, Arslan H, Boyacioglu S, Ozdemir FN. Is Hepatitis C Virus Positivity a Contributing Factor to Occult Hepatitis B Virus Infection in Hemodialysis Patients? Digestive Diseases and Sciences, 51:1962–1966, 2006. (ORIGINAL ARTICLE)
40. Kanbay M, Aydogan T, Bozalan R, Isik A, Uz B, Kaya A, Akcay A. A Rare but serious side effect of Levofloxacin: hypoglycemia in a geriatric patient. Diabetes Care, 29:1716–1717, 2006. (LETTER)
41. Bavbek N, Kargili A, Akcay A, Kaya A. Recurrent hyponatremia associated with citalopram and mirtazapine. American Journal of Kidney Disease, 48:e61–62, 2006. (CASE REPORT)
42. Usta B, Gozdemir M, Turgut F, Sert H, Kanbay M, Demircioglu RI, Akcay A. Does hypocalcemia trigger pulmonary embolism? Medical Hypotheses, 68:464–465, 2006. (LETTER)
43. M Kanbay, T Delibasi, A Kaya, T Aydogan, C Koca, A Akcay, M Duranay, R Yigitoglu. Effect of dialysis type on serum lipids, apolipoproteins and lipoproteins. Renal Failure, 28:567–71, 2006. (ORIGINAL ARTICLE)
44. A Kaya, M Kanbay, O Bayrak, G Eken, L Memis, A Akcay, M Duranay. Primary renal lymphoma associated with hepatitis C virus infection. Leukemia&Lymphoma, 47:1976–1978, 2006. (LETTER)
45. Altay M, Kanbay M, Kurultak I, Altay FA, Aydogan T, Akcay A, Duranay M. A case of bilateral psoas abscesses and lumbar osteomyelitis due to recurrent salmonella infection. Journal of the National Medical Association, 98:1855–1856, 2006. (CASE REPORT)
46. Kanbay M, Akcay A. Reply to Basevitch et Al. Journal of Clinical Gastroenterology, 41:118, 2007. (AUTHOR REPLY)
48. Kanbay M, Alkis M, Turgut F, Uz E, Bavbek N, Akcay A. Hyponatremia Due to an Additive Effect of Carbamazepine and Clarithromycin. Southern Medical Journal, 100:222, 2007. (LETTER)
49. F Turgut, M Kanbay, B Uz, A Carlioglu, Y Selcoki, A Karanfil, O Alici, A Akcay. Forgotten but an important risk factor for infective endocarditis in patients with prosthetic valve: Pedicure. Scandinavian Journal of Infectious Diseases, 39:274–6, 2007. (CASE REPORT
50. Kanbay M, Kasapoglu B, Isik B, Turgut F, Uz E, Bavbek N, Akcay A. H. pylori: A major risk factor for 'non-dipper' circadian variability profile in blood pressure? Medical Hypotheses, 69:463–464, 2007. (LETTER)
51. Kanbay M, Kasapoglu B, Akcay A. An occult risk factor for proteinuria: Helicobacter pylori infection. Medical Hypotheses, 69:709–710, 2007. (LETTER)
52. Kanbay M, Kasapoglu B, Akcay A. An occult risk factor for proteinuria: Helicobacter pylori infection. Medical Hypotheses, 69:709–710, 2007. (LETTER)
53. Duranay M, Kanbay M, Turgut F, Altay M, Akcay A. Comparison of Incidence of Peritonitis between Peritoneal Dialysis Solution Types. Nephron, 106:c57-c60, 2007. (ORIGINAL ARTICLE)
54. F Turgut, M Kanbay, B Isik, A Akcay. Risk factors affecting the incidence of chronic kidney disease. Kidney International, 71:1076, 2007. (AUTHOR REPLY)
55. B Yanik, N Bavbek, T Yanik, I Inegol, M Kanbay, FH Turgut, E Uz, A Akcay. The Effect of Alendronate, Risedronate and Raloxifene on Renal Functions, Based on the Cockcroft and Gault Method, in Postmenopausal Women. Renal Failure, 29:471–476, 2007. (ORIGINAL ARTICLE)
56. Kanbay M, Bavbek N, Delibasi T, Koca C, Kaya A, Altay M, Akcay A, Duranay M, Yigitoglu R. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease. Renal Failure, 29:309–313, 2007. (ORIGINAL ARTICLE)
57. M Kanbay, A Akcay, T Delibasi, B Uz, A Kaya, C Koca, F Turgut, N Bavbek, E Uz, M Duranay, R Yigitoglu. Comparison of Effect of Darbepoetin Alfa and Epoetin Alfa on Serum Endothelin Level and Blood Pressure. Advances in Therapy, 24:346–352, 2007. (ORIGINAL ARTICLE)
58. F Turgut, M Kanbay, A Kaya, B Uz, A Akcay. Bilateral renal artery embolization in a case with severe proteinuria secondary to amyloidosis in a hemodialysis patient. Amyloid-Journal of Protein Folding Disorders, 14:157–158, 2007. (CASE REPORT)
59. Selcoki Y, Uz E, Bayrak R, Sahin S, Kaya A, Uz B, Karanfil A, Ozkara A, Akcay A. The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats. Toxicology, 239:53–59, 2007. (ORIGINAL ARTICLE)
60. M Kanbay, B Isik, A Akcay, A Ozkara, F Karakurt, F Turgut, R Aklan, E Uz, N Bavbek, R Yigitoglu, A Covic. Relation between serum calcium, phosphate, parathyroid hormone and ‘non-dipper’ circadian blood pressure variability profile in patients with normal renal function. American Journal of Nephrology, 27:516–521, 2007. (ORIGINAL ARTICLE)
61. Bavbek N, Kargili A, Kaftan O, Karakurt F, Kosar A, Akcay A. Elevated concentrations of soluble adhesion molecules and large plateletes in diabetic patients: Are they markers of vascular disease and diabetic nephropathy? Clinical and Applied Thrombosis/Hemostasis, 13:391–397, 2007. (ORIGINAL ARTICLE)
62. Uz E, Bavbek N, Turgut FH, Kanbay M, Kaya A, Akcay A. Cefuroxime-induced lupus. Journal of the National Medical Association, 99:1066–7, 2007. (CASE REPORT)
63. Kanbay M, Turgut F, Karakurt F, Isik B, Alkan R, Akcay A, Yigitoglu R, Covic A. Relation between Serum Thyroid Hormone and 'Nondipper' Circadian Blood Pressure Variability. Kidney Blood Pressure Research, 30:416–420, 2007. (ORIGINAL ARTICLE)
64. Bavbek N, Akay H, Altay M, Uz E, Turgut F, Uyar ME, Karanfil A, Selcoki Y, Akcay A, Duranay M. Serum BNP concentration and left ventricular mass in CAPD and automated peritoneal dialysis patients. Peritoneal Dialysis International, 27:663–668, 2007. (ORIGINAL ARTICLE)
65. Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, Uz E, Akcay A, Yigitoglu R, Covic A. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions. International Urology and Nephrology, 39:1227–33, 2007. (ORIGINAL ARTICLE)
66. Ozkara A, Turgut F, Selcoki Y, Karanfil A, Metin MR, Kanbay M, Tekin O, Akcay A. Probrain natriuretic Peptide for assessment of efficacy in heart failure treatment. Advances in Therapy, 24:1233–9, 2007. (ORIGINAL ARTICLE)
67. Y Selcoki, F Turgut, M Kanbay, A Ozkara, O Tekin, B Uz, A Akcay. Cardiac valve calcifications and predictive parameters in hemodialysis patients. Central European Journal of Medicine, 2:304–312, 2007. (ORIGINAL ARTICLE)
68. Bayrak O, Turgut F, Karatas OF, Cimentepe E, Bayrak R, Catal F, Atis O, Akcay A, Unal D. Oral beta-Glucan Protects Kidney against Ischemia/Reperfusion Injury in Rats. American Journal of Nephrology, 28:190–196, 2008. (ORIGINAL ARTICLE)
69. Bavbek N, Alkan R, Uz E, Kaftan O, Akcay A. Hyponatremia associated with sodium valproate in a 22-year-old male. Nephrology Dialysis Transplantation, 23:410, 2008. (LETTER)
70. Selcoki Y, Gorpelioglu C, Turgut F, Sarifakioglu E, Ozkara A, Tekin O, Kanbay M, Akcay A. Isotretinoin: is there any arrhythmic effect? International Journal of Dermatology, 47:195–7, 2008. (ORIGINAL ARTICLE)
71. Uz E, Bayrak O, Uz E, Kaya A, Bayrak R, Uz B, Turgut FH, Bavbek N, Kanbay M, Akcay A. Nigella sativa Oil for Prevention of Chronic Cyclosporine Nephrotoxicity: An Experimental Model. American Journal of Nephrology. 28:517–522, 2008. (ORIGINAL ARTICLE)
72. Turgut F, Bayrak O, Kanbay M, Ozkara A, Uz E, Bavbek N, Kargili A, Akcay A. Circadian rhythm of blood pressure in patients with benign prostatic hyperplasia. Scandinavian Journal of Urology and Nephrology, 42:47–52, 2008. (ORIGINAL ARTICLE)
72. Turgut F, Bayrak O, Kanbay M, Ozkara A, Uz E, Bavbek N, Kargili A, Akcay A. Circadian rhythm of blood pressure in patients with benign prostatic hyperplasia. Scandinavian Journal of Urology and Nephrology, 42:47–52, 2008. (ORIGINAL ARTICLE)
73. Altay M, Turgut F, Akay H, Kanbay M, Babali A, Akcay A, Duranay M, Yigitoglu R, Covic A. Dyspepsia in Turkish patients on continuous ambulatory peritoneal dialysis. International Urology and Nephrology, 40:211–7, 2008. (ORIGINAL ARTICLE)
74. A Ozkara, F Turgut, M Kanbay, Y Selcoki, A Akcay. Population-based cardiovascular risk factors in the elderly in Turkey: a cross-sectional survey. Central European Journal of Medicine, 3:173–178, 2008. (ORIGINAL ARTICLE)
75. Bayrak O, Uz E, Bayrak R, Turgut F, Atmaca AF, Sahin S, Yıldırım ME, Kaya A, Cimentepe E, Akcay A. Curcumin protects against ischemia/reperfusion injury in rat kidneys. World Journal of Urology 26:285–291, 2008. (ORIGINAL ARTICLE
76. F Catal, N Bavbek, O Bayrak, E Uz, B Isik, M Karabel, H Degirmencioglu, E Mete, A Akcay. Platelet Parameters in Children with Upper Urinary Tract Infection: Is There a Specific Response? Renal Failure, 30:377-381, 2008. (ORIGINAL ARTICLE)
77. Bayrak O, Bavbek N, Karatas OF, Bayrak R, Catal F, Cimentepe E, Akbas A, Yildirim E, Unal D, Akcay A. Nigella sativa protects against ischaemia/reperfusion
78. Turgut F, Bayrak O, Catal F, Bayrak R, Atmaca AF, Koc A, Akbas A, Akcay A, Unal D. Antioxidant and protective effects of silymarin on ischemia and reperfusion injury in the kidney tissues of rats. International Urology and Nephrology, 40:453–460, 2008. (ORIGINAL ARTICLE)
79. Y Selcoki, B Uz, N Baybek, A Akcay, B Eryonucu. The effects of nocturnal dipping on cardiovascular outcomes and proteinuria in essential hypertensive patients. Central European Journal of Medicine, 3:279–286, 2008. (ORIGINAL ARTICLE)
80. Kanbay M, Kasapoglu B, Turgut F, Akcay A. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney International, 74:967–8, 2008. (AUTHOR REPLY)
81. H Kurtaran, M Erkmen Uyar, B Kasapoglu, C Turkay, T Yilmaz, A Akcay, M Kanbay. Role of Helicobacter Pylori in Pathogenesis of Upper Respiratory System Diseases. Journal of the National Medical Association, 100:1224–1230, 2008. (REVIEW)
82. Kanbay M, Turgut F, Erkmen Uyar M, Akcay A, Covic A. Causes and mechanisms of nondipping hypertension. Clinical Experimental Hypertension, 30:585–597, 2008. (REVIEW)
83. Altay M, Turgut F, Karakurt F, Kaya R, Ecemis Z, Gonen N, Akcay A, Duranay M. Membranoproliferative glomerulonephritis associated with pseudoxanthoma elasticum. International Urology and Nephrology 40:1099–101, 2008. (CASE REPORT)
84. Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. International Urology and Nephrology, 40:1075–82, 2008. (ORIGINAL ARTICLE)
85. Bavbek N, Isik B, Kargili A, Uz E, Uz B, Kanbay M, Turgut F, Karakurt F, Akcay A. Association of obesity with inflammation in occult chronic kidney disease. Journal of Nephrology, 21:761–7, 2008. (ORIGINAL ARTICLE)
86. Karakurt F, Gumus II, Bavbek N, Kargili A, Koca C, Selcoki Y, Ozbek M, Kosar A, Akcay A. Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome. Gynecological Endocrinology, 24:491–7, 2008. (ORIGINAL ARTICLE)
87. Kanbay M, Goldsmith D, Akcay A, Covic A. Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review. Blood Purification, 27:220–30, 2009. (REVIEW)
88. Kanbay M, Kasapoglu B, Akcay A. Sodium bicarbonate vs sodium chloride in preventing contrast medium-induced nephropathy. JAMA, 301:378, 2009. (AUTHOR REPLY)
89. Kanbay M, Covic A, Coca SG, Turgut F, Akcay A, Parikh CR. Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials. International Urology and Nephrology, 41:617–27, 2009. (REVIEW
90. Uz E, Karatas OF, Mete E, Bayrak R, Bayrak O, Atmaca AF, Atis O, Yildirim ME, Akcay A. The effect of dietary ginger (Zingiber officinals Rosc) on renal ischemia/reperfusion injury in rat kidneys. Renal Failure, 31:251–60, 2009. (ORIGINAL ARTICLE)
91. F Turgut, M Kanbay, M Altay, E Uz, N Bavbek, C Koca, S Secilmis, M Duranay, A Akcay, A Covic. Pro-Hepcidin Levels in Peritoneal Dialysis and Hemodialysis Patients. Dialysis&Transplantation, 38:203–8, 2009. (ORIGINAL ARTICLE
92. Gumus II, Uz E, Bavbek N, Kargili A, Yanik B, Turgut FH, Akcay A, Turhan NO. Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? International Urology and Nephrology, 41:927–32, 2009. (ORIGINAL ARTICLE)
93. Turgut F, Akcay A. Renal function estimation in cirrhosis. American Journal of Transplantation, 9:1968, 2009. (AUTHOR REPLY)
94. Akcay A, Nguyen Q, Edelstein CL. Mediators of inflammation in acute kidney injury. Mediators of Inflammation, 2009:137072, 2009. (REVIEW)
95. Bavbek N, Akay H, Uz B, Uz E, Turgut F, Kanbay M, Senes M, Akcay A, Duranay M. The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients. Renal Failure, 32:157–61, 2010. (ORIGINAL ARTICLE)
96. Kargili A, Turgut FH, Karakurt F, Kasapoglu B, Kanbay M, Akcay A. A forgotten but important risk factor for severe hyponatremia: myxedema coma. Clinics (Sao Paulo), 65:447–8, 2010. (LETTER)
97. Kanbay M, Nicoleta M, Selcoki Y, Ikizek M, Aydin M, Eryonucu B, Duranay M, Akcay A, Armutcu F, Covic A. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clinical Journal of American Society of Nephrology, 5:1780–6, 2010. (ORIGINAL ARTICLE)
98. Bavbek N, Kasapoglu B, Isik A, Kargili A, Kirbas I, Akcay A. Olmesartan associated with acute renal failure in a patient with bilateral renal artery stenosis. Renal Failure, 32:1115–72, 2010. (CASE REPORT)
99. Turkmen K, Martin J, Akcay A, Nguyen Q, Ravichandran K, Faubel S, Pacic A, Ljubanović D, Edelstein CL, Jani A. Apoptosis and autophagy in cold preservation ischemia. Transplantation, 91:1192–7, 2011. (ORIGINAL ARTICLE)
100. Akcay A, Nguyen Q, He Z, Turkmen K, Lee DW, Andres-Hernando A, Altmann C, Toker A, Pacic A, Ljubanovic DG, Jani A, Faubel S, Edelstein CL. IL–33 Exacerbates Acute Kidney Injury. Journal of American Society of Nephrology, 22:2057–67, 2011. (ORIGINAL ARTICLE)
101. Yakut ZI, Karadag R, Akcay A, Bavbek N, Akay H, Koktener A. Effect of dialysis type on orbital vascular flow in patients with end-stage renal disease. Renal Failure. 2012;34(6):691-6. (ORIGINAL ARTICLE)
102. Unverdi S, Ceri M, Unverdi H, Yilmaz R, Akcay A, Duranay M. Postpartum persistent proteinuria after preeclampsia: a single-center experience. Wien Klin Wochenschr. 2013 Feb;125(3-4):91-5. (ORIGINAL ARTICLE)
103. Kim HJ, Lee DW, Ravichandran K, O Keys D, Akcay A, Nguyen Q, He Z, Jani A, Ljubanovic D, Edelstein CL. NLRP3 inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury. J Pharmacol Exp Ther. 2013 Sep;346(3):465-72. (ORIGINAL ARTICLE)
104. Yilmaz H, Bilgiç MA, Bavbek N, Akcay A. Cefpodoxime proxetil-related hemolysis and acute interstitial nephritis. Curr Drug Saf. 2013 Apr;8(2):145-7. (CASE REPORT)
105. Unverdi S, Ceri M, Uz E, Akgul B, Altay M, Kirac Y, Akcay A, Duranay M. The effectiveness of oral essential aminoacids and aminoacids containing dialysate in peritoneal dialysis. Renal Failure. 2014 Oct;36(9):1416-9. (ORIGINAL ARTICLE)
106. Yilmaz H, Gürel OM, Celik HT, Sahiner E, Yildirim ME, Bilgiç MA, Bavbek N, Akcay A. CA 125 levels and left ventricular function in patients with end-stage renal disease on maintenance hemodialysis. Renal Failure. 2014 Mar;36(2):210-6. (ORIGINAL ARTICLE)
107. Yilmaz H, Celik HT, Namuslu M, Inan O, Onaran Y, Karakurt F, Ayyildiz A, Bilgic MA, Bavbek N, Akcay A. Benefits of the neutrophil-to-lymphocyte ratio for the prediction of gestational diabetes mellitus in pregnant women. Exp Clin Endocrinol Diabetes. 2014 Jan;122(1):39-43. (ORIGINAL ARTICLE)
108. Bavbek N, Ceri M, Akdeniz D, Kargili A, Duranay M, Erdemli K, Akcay A, Guz G. Higher thrombin activatable fibrinolysis inhibitor levels are associated with inflammation in attack-free familial Mediterranean fever patients. Renal Failure. 2014 Mar 3. [Epub ahead of print] (ORIGINAL ARTICLE)
109. Bavbek N, Yilmaz H, Erdemli HK, Selcuki Y, Duranay M, Akcay A. Correlation between iron stores and QTc dispersion in chronic ambulatory peritoneal dialysis patients. Renal Failure. 2014 Mar;36(2):187-90. (ORIGINAL ARTICLE)
110. Yilmaz H, Celik HT, Gurel OM, Bilgic MA, Namuslu M, Bozkurt H, Ayyildiz A, Inan O, Bavbek N, Akcay A. Increased serum levels of GDF-15 associated with mortality and subclinical atherosclerosis in patients on maintenance hemodialysis. Herz. 2014 Aug 14. (ORIGINAL ARTICLE)
Profil Ziyaretleri
Son 30 günlük görüntülenme
0
profil görüntülenmesi
Sık Sorulan Sorular
Prof. Dr. Ali Akçay ile nasıl iletişime geçerim?
Prof. Dr. Ali Akçay için online veya telefonla randevu alabilirsin.
Prof. Dr. Ali Akçay için nasıl randevu alabilirim?
Prof. Dr. Ali Akçay ile iletişime geçmek için profil sayfasındaki iletişim bilgilerini kullanabilirsin.
Prof. Dr. Ali Akçay hangi hastanede/klinikte çalışıyor, iletişim bilgileri nedir?
Prof. Dr. Ali Akçay Prof. Dr. Ali Akçay bünyesinde çalışmaktadır. Uzmanının iletişim bilgilerine profilinden ulaşabilirsiniz
Prof. Dr. Ali Akçay kimdir, hangi uzmanlık alanında hizmet veriyor?
Prof. Dr. Ali Akçay, Dahiliye - İç Hastalıkları, Nefroloji uzmanıdır. Ailesel Akdeniz Ateşi (Fmf), Akut Böbrek Yetmezliği, Akut Glomerülonefrit, Amiloidoz, Anemi (kansızlık), Asit Baz Dengesi Bozukluğu, Ateş (Nedeni Bilinmeyen Ateş), Bacaklarda şişlik, Böbrek Hastalıkları, Böbrek Yetmezliği alanlarında hizmet veriyor.
Profil Ziyaretleri
Son 30 günlük görüntülenme
0
profil görüntülenmesi